福光股份(688010.SH):公司投影光機主要應用於激光電視、智能家用投影等
格隆匯2月21日丨福光股份(688010.SH)披露投資者關係活動記錄表顯示,公司投影光機主要應用於激光電視、智能家用投影、AR、可穿戴設備等。2023年,公司投影光機技術實現突破,成功開發三色激光長焦、三色激光超短焦、超薄手機投影光機、Micro-LED單色投影光機及其核心元器件的加工、裝配、檢測工藝。2024年,公司堅持升級投影光機產品,響應市場及客戶需求,持續開發便攜輕量化投影光機、高亮度LCD投影光機、4K三色激光投影光機、MicroLED彩色投影光機及其核心元器件的加工、裝配、檢測工藝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.